Cellular Immunology Proficiency Testing Program

Malignant Leukocyte Immunophenotyping

Guidelines

NCCLS. Clinical Applications of Flow Cytometry: Immunophenotyping of Leukemic Cells; Approved Guidelines. 1998. Vol 18(8), H43-A.

Journal References

Bain, B.J., D. Barnett, D. Linch, E. Matutes, and J.T. Reilly. 2002. Revised guidelines on immunophenotyping in acute leukemias and chronic lymphoproliferative disorders. Clinical Laboratory Haematology 24:1-13.

Braylan, R. C., S. K. Atwater, L. Diamond, J. M. Hassett, M. Johnson, P. G. Kidd, C. Leith, and D. Nguyen. 1997. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting. Cytometry (Communications in Clinical Cytometry) 30:245-248.

Braylan, R. C., A. Orfao, M. J. Borowitz, and B. H. Davis. 2001. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry (Communications in Clinical Cytometry) 46:23-27.

Borowitz, M.J., R. Bray, R. Gascoyne, S. Melnick, J.W. Parker, L. Picker, and M. Stetler-Stevenson. 1997. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry (Communications in Clinical Cytometry) 30:236-244.

Davis, B. H., K. Foucar, W. Szczarkowski, E. Ball, T. Witzig, K. A. Foon, D. Wells, P. Kotylo, R. Johnson, C. Hanson, and D. Bessman. 1997. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry (Communications in Clinical Cytometry) 30:249-263.

Deegan, M.J. 1989. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Archives of Pathology and Laboratory Medicine 113:606-618.

Foon K.A., and R.F. Todd. 1986. Immunologic classification of leukemia and lymphoma. Blood 68:1-31.

Fukushima, P.I., P.K.T. Nguyen, P. O'Grady, M. Stetler-Stevenson. 1996. Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. Cytometry (Communications in Clinical Cytometry) 26:243-252.

Jennings C.D., and R.F. Todd. 1997. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 90:2863-2892.

Stelzer, G. T., G. Marti, A. Hurley, P. McCoy, E. J. Lovett, and A. Schwartz. 1997. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry:standardization and validation of laboratory procedures. Cytometry (Communications in Clinical Cytometry) 30:214-230.

Stewart, C. E., F. G. Behm, J. L. Carey, J. Cornbleet, R. E. Duque, S. D. Hudnall, P. E. Hurtubise, M. Loken, R. R. Tubbs, and S. Wormsley. 1997. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry (Communications in Clinical Cytometry) 30:231-235.

Tbakhi, A., M. Edinger, J. Myles, B. Pohlman, and R.T. Tubbs. 1996. Flow Cytometric Immunohenotyping of non-Hodgkin's lymphomas and related disorders. Cytometry (Communications in Clinical Cytometry) 25:113-124.